Cargando…
Clinical Presentation and Evaluation of Dermatomyositis
Dermatomyositis (DM) is a chronic inflammatory disorder of the skin and muscles. Evidence supports that DM is an immune-mediated disease and 50–70% of patients have circulating myositis-specific auto-antibodies. Gene expression microarrays have demonstrated upregulation of interferon signaling in th...
Autores principales: | Marvi, Umaima, Chung, Lorinda, Fiorentino, David F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482801/ https://www.ncbi.nlm.nih.gov/pubmed/23112358 http://dx.doi.org/10.4103/0019-5154.100486 |
Ejemplares similares
-
Digital Ischemic Loss in Systemic Sclerosis
por: Marvi, Umaima, et al.
Publicado: (2010) -
Polymyositis and dermatomyositis: Disease spectrum and classification
por: Raychaudhuri, Siba P, et al.
Publicado: (2012) -
Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey
por: Linos, Eleni, et al.
Publicado: (2013) -
Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence
por: Fiorentino, David F., et al.
Publicado: (2022) -
Evidence supports blind screening for internal malignancy in dermatomyositis: Data from 2 large US dermatology cohorts
por: Leatham, Hayley, et al.
Publicado: (2018)